Paralel Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.29M Buy
13,322
+3,212
+32% +$914K 0.2% 24
2026
Q1
$1.75M Hold
10,110
0.07% 85
2025
Q4
$2.59M Hold
10,110
0.1% 63
2025
Q3
$2.63M Buy
10,110
+14
+0.1% +$3.68K 0.1% 65
2025
Q2
$2.47M Buy
10,096
+2,856
+39% +$712K 0.1% 75
2025
Q1
$1.92M Hold
7,240
0.08% 84
2024
Q4
$1.84M Buy
7,240
+656
+10% +$176K 0.08% 88
2024
Q3
$2.09M Hold
6,584
0.09% 80
2024
Q2
$2.46M Buy
6,584
+2,640
+67% +$891K 0.12% 36
2024
Q1
$1.37M Hold
3,944
0.06% 93
2023
Q4
$1.81M Hold
3,944
0.09% 81
2023
Q3
$1.92M Buy
3,944
+49
+1% +$23K 0.11% 50
2023
Q2
$1.74M Sell
3,895
-278
-7% -$140K 0.09% 73
2023
Q1
$2.03M Buy
4,173
+110
+3% +$54.4K 0.11% 38
2022
Q4
$2.08M Buy
+4,063
New +$2.14M 0.12% 29

Other funds holding HUM

Paralel Advisors's HUM Position: Q2 2026 in Review

Paralel Advisors increased its Humana (HUM) stake by 32% in Q2 2026, buying an estimated $914K and bringing the position to 13,322 shares worth $5.29M. The position accounts for 0.2% of the portfolio, ranked #24.

Paralel Advisors first reported a position in HUM in Q4 2022 and has held it in 15 quarters since. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Paralel Advisors held 13,322 shares of Humana worth $5.29M as of Q2 2026.
  • Paralel Advisors bought 3,212 Humana shares in Q2 2026, an estimated $914K.
  • Humana made up 0.2% of Paralel Advisors's portfolio in Q2 2026, its #24 holding.
  • Paralel Advisors first reported a position in Humana in Q4 2022 and has held it in 15 quarters since.
  • 925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Paralel Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.